blonanserin

Known as: 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta(b)pyridine, Cycloocta(b)pyridine, 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro- 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2018
0102019992018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Blonanserin differs from currently used serotonin 5-HT2A/dopamine-D2 receptor antagonists in that it exhibits higher affinity for… (More)
  • figure 1
  • figure 3
  • figure 5
Is this relevant?
2014
2014
Atypical antipsychotic drugs (AAPDs) have been suggested to be more effective in improving cognitive impairment in schizophrenia… (More)
Is this relevant?
2014
2014
BACKGROUND This study aims to determine the effectiveness of blonanserin (BNS) on the cognitive and social functions of patients… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2013
2013
Blonanserin was developed as an antipsychotic drug in Japan and approved for the treatment of schizophrenia. It belongs to a… (More)
  • table 1
  • figure 1
Is this relevant?
2013
2013
Blonanserin is an atypical antipsychotic drug (APD) which, compared to other atypical APDs, is a relatively selective serotonin… (More)
  • figure 1
  • figure 2
Is this relevant?
2012
2012
Although blonanserin, a novel atypical antipsychotic agent with dopamine D(2)/serotonin 5-HT(2A) antagonistic properties… (More)
Is this relevant?
2011
2011
To clarify the mechanisms of action of blonanserin, an atypical antipsychotic drug, we studied the effects of systemic… (More)
Is this relevant?
2010
2010
Blonanserin is a novel potent dopamine D2 and serotonin 5-HT2 antagonist for treating schizophrenia. The aim of this study was to… (More)
  • figure 1
  • table 1
Is this relevant?
2010
2010
OBJECTIVES The objective of this study was to evaluate the efficacy and tolerability of blonanserin for the treatment of Korean… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2009
2009
BACKGROUND Blonanserin is a novel atypical antipsychotic agent with potent dopamine D(2) and serotonin 5-HT(2) antagonist… (More)
Is this relevant?